Up to a Quarter of Children With Cancer Develop Breakthrough Clinical Varicella Despite Receiving Post-exposure Prophylaxis With Varicella Immunoglobulin: A Single Center UK Experience Over 3 Years

J Pediatr Hematol Oncol. 2021 Jan;43(1):36-37. doi: 10.1097/MPH.0000000000001835.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adolescent
  • Chickenpox / chemically induced
  • Chickenpox / epidemiology
  • Chickenpox / pathology*
  • Child
  • Child, Preschool
  • Female
  • Herpesvirus 3, Human / drug effects*
  • Humans
  • Immunoglobulin G / adverse effects*
  • Infant
  • Infant, Newborn
  • Male
  • Neoplasms / drug therapy*
  • Neoplasms / pathology
  • Post-Exposure Prophylaxis / methods*
  • Prognosis
  • United Kingdom / epidemiology

Substances

  • Immunoglobulin G